<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01890382</url>
  </required_header>
  <id_info>
    <org_study_id>The Pro Elderly Study</org_study_id>
    <nct_id>NCT01890382</nct_id>
  </id_info>
  <brief_title>Protein Intake and Resistance Training in Aging</brief_title>
  <official_title>Effect of Protein Intake Associated With Resistance Training in Elderly Frail Individuals.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The combination of protein and resistance exercise seems to be one of the most effective
      tools to counteract sarcopenia. Randomized controlled trials supporting this possibility are
      still scarce. These series of clinical trials aim to investigate the therapeutic role of
      protein ingestion combined with resistance training in frail elderly participants. These
      studies will mainly address the following research questions: Is the protein source (i.e.,
      whey versus soy) a factor in inducing a differential anabolic response? Does dietary protein
      consumption dictate a whey/training-induced anabolic response? Does leucine supplementation
      promote anabolic response? Does co-supplementation of creatine and whey protein foster an
      anabolic response?
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>lean mass</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by Dual-energy X-ray absorptiometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>muscle function</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by a battery of physical tests</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>bone mass</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by Dual-energy X-ray absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulin sensitivity</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by HOMA index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inflammatory response</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by pre- and pro-inflammatory interleukines</description>
  </secondary_outcome>
  <other_outcome>
    <measure>satellite cells (per fiber)</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by histology technique</description>
  </other_outcome>
  <other_outcome>
    <measure>type I and type 2 fibre cross-sectional Ã¡rea (cm2)</measure>
    <time_frame>3 months</time_frame>
    <description>assessed by histology technique</description>
  </other_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Frail Elderly</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>alanine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>whey protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>soy protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>leucine supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>whey plus creatine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey protein</intervention_name>
    <description>20 g twice a day (morning and evening)</description>
    <arm_group_label>whey protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>whey plus creatine</intervention_name>
    <description>whey protein combined with creatine (20 g and 2,5 twice a day, respectively)</description>
    <arm_group_label>whey plus creatine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>leucine supplementation</intervention_name>
    <description>7,5 g/d three times per day</description>
    <arm_group_label>leucine supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>soy protein</intervention_name>
    <description>40 g twice a day</description>
    <arm_group_label>soy protein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elderly people

          -  frailty or pre-frailty, according to Fried et al., (2001) criteria.

        Exclusion Criteria:

          -  cancer

          -  cachexia

          -  non-controlled chronic diseases

          -  physical limitations to exercise

          -  use of drugs that may interfere in protein balance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Gualano, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bruno Gualano, Professor</last_name>
    <phone>551130913096</phone>
    <email>gualano@usp.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05508030</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vitor Procopio</last_name>
      <phone>551130913096</phone>
      <email>vitorproc@usp.br</email>
    </contact>
    <investigator>
      <last_name>Bruno Gualano, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2013</study_first_submitted>
  <study_first_submitted_qc>June 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2013</study_first_posted>
  <last_update_submitted>July 1, 2013</last_update_submitted>
  <last_update_submitted_qc>July 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Bruno Gualano</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>resistance exercise</keyword>
  <keyword>protein</keyword>
  <keyword>creatine</keyword>
  <keyword>leucine</keyword>
  <keyword>aging</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

